{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:10:08Z","timestamp":1778425808565,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00336500 for Young Wha Koh"],"award-info":[{"award-number":["RS-2024-00336500 for Young Wha Koh"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45469-2","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:44:53Z","timestamp":1774183493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM29 promotes epithelial\u2013mesenchymal transition, angiogenesis, and stromal remodeling in lung adenocarcinoma: integrated validation at histologic, transcriptomic, and protein levels"],"prefix":"10.1038","volume":"16","author":[{"given":"Yoonjung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokjin","family":"Haam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Wha","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"issue":"1","key":"45469_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74 (1), 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"45469_CR2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl. J. Med. 373 (17), 1627\u20131639 (2015).","journal-title":"N Engl. J. Med."},{"issue":"2","key":"45469_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria, J. C. et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl. J. Med. 378 (2), 113\u2013125 (2018).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"45469_CR4","doi-asserted-by":"publisher","first-page":"e000060","DOI":"10.1136\/esmoopen-2016-000060","volume":"1","author":"F Morgillo","year":"2016","unstructured":"Morgillo, F., Della Corte, C. M., Fasano, M. & Ciardiello, F. Mechanisms of resistance to EGFR-targeted drugs: lung cancer. ESMO Open. 1 (3), e000060 (2016).","journal-title":"ESMO Open."},{"issue":"4","key":"45469_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168 (4), 707\u2013723 (2017).","journal-title":"Cell"},{"issue":"10","key":"45469_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Nisole, S., Stoye, J. P. & Sa\u00efb, A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3 (10), 799\u2013808 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"45469_CR7","doi-asserted-by":"publisher","first-page":"113983","DOI":"10.1016\/j.intimp.2024.113983","volume":"147","author":"K Lv","year":"2025","unstructured":"Lv, K., Li, Q., Jiang, N. & Chen, Q. Role of TRIM29 in disease: What is and is not known. Int. Immunopharmacol. 147, 113983 (2025).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"45469_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13046-019-1098-y","volume":"38","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt\/\u03b2-catenin signaling pathway. J. Exp. Clin. Cancer Res. 38 (1), 104 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"45469_CR9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.4143\/crt.2015.381","volume":"48","author":"S-T Tan","year":"2016","unstructured":"Tan, S-T., Liu, S-Y. & Wu, B. TRIM29 Overexpression promotes proliferation and survival of bladder cancer cells through NF-\u03baB signaling. Cancer Res. Treat. 48 (4), 1302\u20131312 (2016).","journal-title":"Cancer Res. Treat."},{"issue":"2","key":"45469_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1101\/gad.253591.114","volume":"29","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes Dev. 29 (2), 171\u2013183 (2015).","journal-title":"Genes Dev."},{"issue":"6","key":"45469_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jcma.2012.04.015","volume":"75","author":"Z-Y Zhou","year":"2012","unstructured":"Zhou, Z-Y., Yang, G-Y., Zhou, J. & Yu, M-H. Significance of TRIM29 and \u03b2-catenin expression in non-small-cell lung cancer. J. Chin. Med. Association. 75 (6), 269\u2013274 (2012).","journal-title":"J. Chin. Med. Association"},{"issue":"5","key":"45469_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2 (5), 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"45469_CR13","doi-asserted-by":"crossref","unstructured":"Gy\u0151rffy, B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br. J. Pharmacol. (2023).","DOI":"10.1111\/bph.16257"},{"issue":"8 Suppl","key":"45469_CR14","first-page":"4244s","volume":"46","author":"KS McCarty Jr","year":"1986","unstructured":"McCarty, K. S. Jr. et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 46 (8 Suppl), 4244s\u20138s (1986).","journal-title":"Cancer Res."},{"issue":"5","key":"45469_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1155\/2007\/175276","volume":"29","author":"WE Mesker","year":"2007","unstructured":"Mesker, W. E. et al. The carcinoma\u2013stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Anal. Cell. Pathol. 29 (5), 387\u2013398 (2007).","journal-title":"Anal. Cell. Pathol."},{"issue":"43","key":"45469_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"45469_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18 (1), 220 (2017).","journal-title":"Genome Biol."},{"key":"45469_CR18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"45469_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle, J. & Gfeller, D. EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol. Biol. 2120, 233\u2013248 (2020).","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"45469_CR20","doi-asserted-by":"publisher","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies, J. et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 7 (12), e51862 (2012).","journal-title":"PLoS One"},{"issue":"12","key":"45469_CR21","doi-asserted-by":"publisher","first-page":"13634","DOI":"10.18632\/oncotarget.7215","volume":"7","author":"XM Zhou","year":"2016","unstructured":"Zhou, X. M. et al. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN\/AKT\/mTOR signal pathway. Oncotarget 7 (12), 13634\u201313650 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"45469_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-021-01474-9","volume":"20","author":"T Jiang","year":"2021","unstructured":"Jiang, T. et al. CircIL4R activates the PI3K\/AKT signaling pathway via the miR-761\/TRIM29\/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Mol. Cancer. 20 (1), 167 (2021).","journal-title":"Mol. Cancer"},{"issue":"3","key":"45469_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3892\/or.2017.5364","volume":"37","author":"J Xu","year":"2017","unstructured":"Xu, J., Li, Z., Su, Q., Zhao, J. & Ma, J. TRIM29 promotes progression of thyroid carcinoma via activating P13K\/AKT signaling pathway. Oncol. Rep. 37 (3), 1555\u20131564 (2017).","journal-title":"Oncol. Rep."},{"key":"45469_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","volume":"165","author":"M Karimi Roshan","year":"2019","unstructured":"Karimi Roshan, M. et al. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochimie 165, 229\u2013234 (2019).","journal-title":"Biochimie"},{"key":"45469_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2019.01.013","volume":"130","author":"E Perumal","year":"2019","unstructured":"Perumal, E. et al. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of \u03b2-catenin and snail\/slug in non-small cell lung carcinoma cells. Lung Cancer. 130, 25\u201334 (2019).","journal-title":"Lung Cancer"},{"issue":"13","key":"45469_CR26","doi-asserted-by":"publisher","first-page":"13488","DOI":"10.18632\/aging.103451","volume":"12","author":"W Xu","year":"2020","unstructured":"Xu, W., Chen, B., Ke, D. & Chen, X. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin. Aging (Albany NY). 12 (13), 13488\u201313501 (2020).","journal-title":"Aging (Albany NY)"},{"issue":"41","key":"45469_CR27","doi-asserted-by":"publisher","first-page":"21541","DOI":"10.1074\/jbc.M116.730960","volume":"291","author":"M D\u00fckel","year":"2016","unstructured":"D\u00fckel, M. et al. The breast cancer tumor suppressor TRIM29 Is expressed via ATM-dependent signaling in response to hypoxia. J. Biol. Chem. 291 (41), 21541\u201321552 (2016).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"45469_CR28","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s13277-013-0843-7","volume":"34","author":"ZP Tang","year":"2013","unstructured":"Tang, Z. P., Cui, Q. Z., Dong, Q. Z., Xu, K. & Wang, E. H. Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways. Tumour Biol. 34 (5), 2835\u20132842 (2013).","journal-title":"Tumour Biol."},{"issue":"10","key":"45469_CR29","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.21037\/jtd.2017.09.29","volume":"9","author":"K-X Xi","year":"2017","unstructured":"Xi, K-X. et al. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival. J. Thorac. Disease. 9 (10), 4017\u20134026 (2017).","journal-title":"J. Thorac. Disease"},{"issue":"9","key":"45469_CR30","first-page":"11348","volume":"8","author":"T Zhang","year":"2015","unstructured":"Zhang, T. et al. Tumor-stroma ratio is an independent predictor for survival in NSCLC. Int. J. Clin. Exp. Pathol. 8 (9), 11348\u201311355 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"45469_CR31","first-page":"100247","volume":"25","author":"MA Smit","year":"2020","unstructured":"Smit, M. A. et al. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study. Cancer Treat. Res. Commun. 25, 100247 (2020).","journal-title":"Cancer Treat. Res. Commun."},{"key":"45469_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran, L. & Erez, N. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment. Front. Immunol. 10, 1835 (2019).","journal-title":"Front. Immunol."},{"issue":"1","key":"45469_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J. Hematol. Oncol. 15 (1), 34 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"45469_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1073\/pnas.1613855114","volume":"114","author":"F Bordeleau","year":"2017","unstructured":"Bordeleau, F. et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc. Natl. Acad. Sci. U S A. 114 (3), 492\u2013497 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"45469_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell. Res. 19 (2), 156\u2013172 (2009).","journal-title":"Cell. Res."},{"issue":"1","key":"45469_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue, W. et al. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell. Mol. Life Sci. 81 (1), 79 (2024).","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"45469_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 29 (3), 212\u2013226 (2019).","journal-title":"Trends Cell Biol."},{"issue":"1","key":"45469_CR38","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/s41467-019-13441-6","volume":"10","author":"LG Karacosta","year":"2019","unstructured":"Karacosta, L. G. et al. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nat. Commun. 10 (1), 5587 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45469-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:05:22Z","timestamp":1778425522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45469"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45469-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14505"}}